What Is NMN? A Clear Guide to Nicotinamide Mononucleotide and NAD+

NMN (nicotinamide mononucleotide) is a naturally occurring compound made from vitamin B3 that the body uses to produce NAD+, a coenzyme found in every cell and involved in energy metabolism. NAD+ levels appear to fall as we get older, and NMN has become one of the most studied ways to support them. Human research is still at an early stage, but studies suggest oral NMN raises blood NAD+ levels and is well tolerated at the doses tested so far.

This guide explains what NMN is, how it works, what the research does and does not show, and what to look for if you are considering it. It is the starting point for our NMN series, and each section links to a deeper article.

NMN in one minute

• What it is: a nucleotide built from nicotinamide (a form of vitamin B3), a ribose sugar and a phosphate group.
• Why people take it: it is a direct precursor of NAD+, one enzymatic step away.
• Where it is found: in small amounts in foods such as broccoli, cabbage, cucumber, edamame and avocado, far below the amounts used in studies.
• What research shows: human trials consistently report higher blood NAD+; effects on how people feel and function are still being studied.
• Safety: trials of up to 1,200 mg a day for several weeks have reported good tolerability.

What is NAD+ and why does it matter?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme that shuttles electrons in the reactions that turn food into usable cellular energy. It is also used by enzymes such as sirtuins and PARPs, which are involved in cell maintenance and DNA repair processes. Because it is used up and recycled constantly, the body needs a steady supply of building blocks to keep making it.

Researchers have observed that NAD+ levels decline in many tissues with age. Reviews in Science and Nature Reviews Molecular Cell Biology describe this decline and discuss why it has become a major focus of ageing research. Why NAD+ falls is still debated: rising activity of NAD+-consuming enzymes such as CD38 and reduced recycling are both thought to play a part.

How the body makes NAD+

The body can make NAD+ from several starting points: the amino acid tryptophan, nicotinic acid (niacin), nicotinamide, nicotinamide riboside (NR) and NMN. Most NAD+ is recycled through the so-called salvage pathway, in which nicotinamide is turned into NMN and then into NAD+. That is why NMN gets so much attention: it sits right at the end of the main recycling route. For a side-by-side look at the different precursors, read NMN vs NR vs NAD+: which precursor does what.

How does NMN work in the body?

Once swallowed, NMN is absorbed from the gut. Some of it is thought to be converted to NR before entering cells, while research in mice identified a dedicated NMN transporter, called Slc12a8, in the small intestine. Scientists are still working out how much of each route matters in humans. Inside cells, the enzyme NMNAT converts NMN into NAD+.

Human studies measure the end result in blood. Trials in Japan, China and the US have reported that taking NMN for several weeks raises blood NAD+ or related metabolites compared with placebo.

What does the research on NMN suggest?

Much of the excitement around NMN started with animal research. A widely cited 2016 study in Cell Metabolism gave mice NMN in their drinking water for a year and reported that it lessened several age-associated physiological changes. Animal results do not automatically apply to people, which is why human trials matter.

Human research so far includes:

• NAD+ levels: several randomised, placebo-controlled trials report that NMN raises blood NAD+ in a dose-dependent way.
• Physical performance: some trials have looked at walking distance, grip strength, gait speed and aerobic capacity, with mixed but encouraging results.
• Metabolic markers: a small 2021 study in Science looked at muscle insulin sensitivity in postmenopausal women with prediabetes.

Most of these studies were small and short, lasting 6 to 12 weeks, so research is ongoing. We break each trial down in NMN benefits: what the research actually says.

How much NMN do people take?

Human trials have used between 250 mg and 1,200 mg a day, most often 250 mg to 600 mg. In one 2023 dose-comparison trial in healthy middle-aged adults, blood NAD+ rose more at 600 mg and 900 mg than at 300 mg. Most people take NMN in the morning. Our NMN dosage and how to take it guide covers timing, food and formats in detail.

Is NMN safe?

In the clinical trials published so far, NMN has been well tolerated, with no serious adverse effects linked to it at the doses studied. A 2022 safety study of 1,250 mg a day for four weeks reported no safety concerns in healthy adults. Long-term data beyond a few months are limited, though, and some groups should take extra care. See NMN side effects and safety for the full picture.

Capsules, powder or liquid: does the format matter?

NMN is sold as capsules, loose powder, sublingual tablets and liquids. Absorption of nutrients can depend on how they are delivered, which is why some products use liposomes, tiny fat-based spheres that wrap the active ingredient. Direct human comparisons of NMN formats are still scarce, so it is fair to say this is an area where research is developing. If you want to understand the delivery side, read what liquid liposomal NMN is and why absorption matters more than you think.

How to choose an NMN supplement

• Form: look for beta-NMN (β-NMN), the form used in research.
• Purity and testing: ask for independent certificates of analysis.
• Clear dose per serving: you should be able to work out how many milligrams you take each day.
• Manufacturing standards: GMP-certified production and transparent sourcing.
• Honest marketing: be wary of products promising to reverse ageing or treat disease. Food supplements cannot make those claims.

Our own liposomal NMN liquid drops are made in Switzerland using a liposomal delivery format, and they are the product our customers come back to most. Whatever you choose, use the checklist above.

If convenience matters to you, a liquid liposomal NMN is one of the easiest formats to take every day.

The bottom line

NMN is a vitamin B3-derived building block of NAD+, a coenzyme central to cellular energy. Human studies suggest it reliably raises blood NAD+ and is well tolerated in the short term, while its wider effects are still being researched. It works best as one part of a routine built on sleep, movement and a balanced diet.

Frequently asked questions

What does NMN stand for?

NMN stands for nicotinamide mononucleotide, a nucleotide made from nicotinamide (vitamin B3), ribose and phosphate.

Is NMN the same as NAD+?

No. NMN is a precursor that the body converts into NAD+. NAD+ itself is a larger molecule that is generally thought to be less efficiently absorbed when taken orally.

Does NMN occur naturally in food?

Yes, in small amounts in foods such as broccoli, edamame, cucumber and avocado, but the quantities are tiny compared with the doses used in studies.

How long does NMN take to work?

Trials that measured blood NAD+ typically saw increases within a few weeks. Any effect on how you feel is individual and still being researched.

Who should avoid NMN?

Pregnant or breastfeeding women, children, and anyone with a medical condition or taking medication should speak to a doctor first.

This article is for general information only and is not medical advice. Food supplements are not intended to diagnose, treat, cure or prevent any disease and should not replace a varied, balanced diet and healthy lifestyle. Speak to your doctor or pharmacist before taking NMN, especially if you are pregnant, breastfeeding, taking medication or managing a health condition.

References

1. Verdin E (2015). NAD⁺ in aging, metabolism, and neurodegeneration. Science. PubMed 26785480
2. Covarrubias AJ et al. (2021). NAD⁺ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. PubMed 33353981
3. Rajman L, Chwalek K, Sinclair DA (2018). Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism. PubMed 29514064
4. Grozio A et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nature Metabolism. PubMed 31131364
5. Mills KF et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism. PubMed 28068222
6. Irie J et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. PubMed 31685720
7. Yoshino M et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. PubMed 33888596
8. Yi L et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. PubMed 36482258
9. Igarashi M et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. PubMed 35927255
10. Fukamizu Y et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. PubMed 36002548